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Case presentation
A 38-year-old man was evaluated at the Duke University Med-
ical Center for routine followup of known proteinuria for 19
years. Qualitative proteinuria was first detected during routine
urinalysis when he entered military service at age 19. Repeti-
tive examination of randomly collected urine specimens over the
next several days documented the presence of proteinuna, and
the patient was then admitted to Wilford Hall USAF Medical
Center for further evaluation.
On admission, the patient was asymptomatic. He had no his-
tory of signs or symptoms of any form of genitourinary disease.
The patient denied any prior hospitalizations or health examina-
tions. There was no family history of kidney disease. Physical
examination revealed a healthy appearing young man with a nor-
mal body build: height, 5'6"; weight, 147 lbs. Accentuated lum-
bar lordosis was not apparent. The supine blood pressure was
120/78 mm Hg; the remainder of the physical examination was
within normal limits. Laboratory examination showed a normal
hemogram including a hematocrit of 44% and an erythrocyte
sedimentation rate of 9 mm/hour. Routine urinalysis was within
normal limits except for 1+ proteinuria. Microscopic hematuria,
pyuria, and casts were not present. Serum protein electro-
phoresis was normal. Blood chemistries were also normal, in-
cluding a BUN of 16 mgldl and a serum creatinine concentration
of 0.9 mg/dl. Urine protein excretion was 0.64 g/day. Qualitative
tests for protein on serial urine collections on 2 consecutive days
revealed protein during maintenance of the quiet, upright am-
bulatory posture but none during recumbency. Inulin and PAH
clearances in the recumbent posture were 135 and 655 ml!
mm/i .73 m2 body surface area, respectively. Chest x-ray and ex-
cretory urography were normal. A percutaneous renal biopsy re-
vealed normal renal tissue on light microscopy; electron micros-
copy was not performed. The patient was discharged to duty
with a clinical diagnosis of "fixed and reproducible orthostatic
proteinuria."
The patient remained asymptomatic without subsequent ill-
ness or hospitalization throughout the entire 19-year period.
Routine followup evaluations were carried out subsequently at
4-, 9-, and 19-year intervals. At 4 years he continued to exhibit
qualitative proteinuria during assumption and maintenance of a
quiet upright ambulatory posture. The urine sediment was nor-
mal. The 24-hour excretion of protein was 0.42 g, and the en-
dogenous creatinine clearance was 115 mI/mm/i .73 m2 body sur-
face area. Maximum urine concentrating ability was normal.
Physical examination at 9 years again was within normal limits.
He continued to exhibit qualitative proteinuria only during the
upright posture. The endogenous creatinine clearance was 98 ml!
minI! .73 m2 body surface area. At the 19-year follow-up, blood
chemistries, chest x-ray, and electrocardiogram again were
normal. Repeated qualitative tests of serial urine collections re-
vealed proteinuria in the upright posture on one day, but not on
another. The endogenous creatinine clearance was 145 mllmim
1.73 m2 body surface area, and the 24-hour excretion of total pro-
tein was less than 0.08 g.
Discussion
DR. RoscoE R. ROBINSON (Florence McAlister
Professor of Medicine, and Director, Division of
Nephrology, Duke University Medical Center, Dur-
ham, North Carolina): This man has had qualitative
proteinuria for at least 19 years. Prior to his most
recent examination, he always had exhibited "fixed
and reproducible" orthostatic proteinuria. On his
last examination in 1979, however, qualitative evi-
dence of upright proteinuria was detected on one
day, but not on another; hence, the pattern of pro-
teinuria became "transient" or "intermittent." The
sporadic presence of upright proteinuria in this pa-
tient perhaps explains why only a small amount of
protein was detected on quantitative examination of
a 24-hour urine sample. Qualitative proteinuria was
the only clinically significant finding throughout this
patient's 19-year observation period; at no time was
its presence associated with urinary sediment ab-
normalities, evidence of a systemic disease known
to affect the kidneys, or renal functional impair-
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ment. Proteinuria in this patient thus was always an
"isolated" clinical phenomenon.
Diagnostic and prognostic uncertainty continue
to surround the detection of qualitative proteinuria
in asymptomatic individuals who seem to be in good
health. The uncertainty is most pronounced when,
as in this patient, the amount of proteinuria is mod-
est, and when there is no evidence of systemic dis-
ease, impaired renal function, abnormal urine sedi-
ment, anatomic alteration as shown by excretory
urography, and no history of renal or urologic dis-
ease. The unsuspected finding of qualitative pro-
teinuria as an "isolated" event gives rise to two
simple but important questions: (1) does proteinuria
reflect the presence of underlying renal disease, and
if so, (2) will the disease eventually cause morbidity
or death? Unfortunately, neither of these questions
can be answered with confidence in an individual
patient because the causes and mechanisms of this
type of proteinuric syndrome have not yet been
clarified and are undoubtedly multiple.
Significant advances have been made in our un-
derstanding of the mechanisms of proteinuria in
several experimental and clinical circumstances in
the past decade. For this reason, before continuing
our discussion of the clinical significance of "isolat-
ed" proteinuria, I would like to review briefly first,
our present concepts regarding the manner in which
a small amount of protein can enter the urine, and
second, the mechanisms of pathologic proteinuria.
Excretion of protein by the healthy kidney
The daily urinary excretion of protein in appar-
ently healthy adults is 80 24 mg according to
Berggard [II. Other estimates have differed slightly,
but the total daily excretion of as much as 150 mg is
probably within two standard deviations of the av-
erage, and this amount therefore can be accepted as
a close approximation of the upper limit of normal.
Nevertheless, the relatively inexact definition of the
"normal" range of total protein excreted by the
healthy kidney poses a practical problem as one at-
tempts to distinguish between normal and abnormal
excretion of protein, particularly in patients with
only slight proteinuria. This definition is obscured
further when complicating factors such as exercise
and increased catecholamine activity are present.
In a healthy individual, the small amount of protein
in the urine is sufficient to permit detection with the
usual qualitative tests if the urine is a concentrated
specimen [2, 3]. It is useful, therefore, if we have
some estimate of urine concentration when consid-
ering the significance of a qualitative reaction for
protein, because a concentrated urine can permit
the detection of a normal amount of protein; con-
versely, a dilute urine can hinder the detection of an
abnormal amount of protein.
Composition. Detailed analysis of the composi-
tion of normal urinary proteins requires physico-
and immunochemical or radiosotopic techniques.
Using these techniques, Poortman and Jeanloz have
estimated that approximately 60% by weight of the
total urine protein consists of normal plasma pro-
teins in the healthy adult, whereas the remaining
fraction derives directly from renal and other uro-
genital tissues [4]. The plasma proteins in healthy
urine include albumin (about 40% of the total pro-
tein excretion), a large and heterogeneous array of
small-sized immunoglobulins and their fragments,
enzymes, peptide hormones, and other proteins.
Normally, IgG or its fragments represents about 5%
to 10% of the total urine protein, light chains com-
prise approximately 5%, and IgA accounts for ap-
proximately 3% (of which 90% is secretory IgA) [1,
5]; 1gM and IgD are not usually detectable [1].
Thus, the proteins in healthy urine include albumin
(40%), tissue proteins and antigens or glycoproteins
of uroepithelial origin, for example, Tamm-Horsfall
mucoproteins (40%), and immunoproteins and oth-
er plasma proteins (20%). This composition can be
altered by both normal and abnormal events. For
example, the increase in protein excretion after ex-
ercise is accounted for primarily by an increase in
the excretion of proteins that are identical to those
in plasma [4].
Anatomy of ultrafiltration. The exact anatomic
location of the glomerular ultrafiltration barrier for
macromolecules is uncertain. On the one hand, his-
tochemical localization of macromolecular enzymes
suggests that the filtration slit membrane between
the epithelial foot processes might be the primary
filtration barrier [6]; electron microscopic local-
ization of graded dextran particles suggests, on the
other hand, that the subendothelial portion of the
basement membrane might be the limiting barrier
[7, 8]. It seems most likely that all of the anatomic
components of the capillary wall contribute to the
limitation of transglomerular protein passage but
that in a given experimental or clinical circum-
stance, molecular size, shape, or charge might be
the determining factor [91. For example, the pres-
ence of fixed glomerular anions within the endothe-
hum and lamina rara interna might provide a major
barrier to the filtration of larger circulating poly-
anions such as albumin, the substance of the base-
ment membrane might restrict by size the passage
of neutral macromolecules, and the slit diaphragm
and lamina rara externa might prevent the passage
of cationic macromolecules.
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Filtration and resorption. The amount and com-
position of normal urine protein are primarily the
net consequence of filtration by the glomeruli and
subsequent tubular reabsorption of proteins. Intra-
epithelial production and direct addition to tubule
fluid account for some of the protein in healthy
urine (for example, Tamm-Horsfall protein and se-
cretory IgA). Renal tubular secretion is another
possible mechanism of proteinuria, but proof of its
existence has not been established.
There is little question that most of the albumin
and other plasma proteins in normal glomerular fil-
trate undergo subsequent renal tubular reabsorption
along the nephron. Albumin concentrations of 0.1
to 3.0 mgldl have been reported in fluid samples ob-
tained by micropuncture from the proximal con-
voluted tubule and Bowman's space [10-13]. These
concentrations indicate that the usual filtered load
of protein far exceeds the amount in the urine; thus
renal tubular reabsorption must take place along the
nephron. Studies using micropuncture [11] and per-
fusion of isolated renal tubules [14] indicate that
much of this protein is reabsorbed in the proximal
tubule, although a small fraction might be reab-
sorbed in later nephron segments [11]. The mecha-
nism of protein absorption, although unclear, prob-
ably involves selective endocytosis. Transport ki-
netics of the absorptive process are even less well
understood, but some investigators have suggested
that the absorptive maximum for albumin resides
close to the plasma threshold, whereas the absorp-
tive process for low-molecular-weight proteins ex-
hibits considerable "splay" and its maximum might
exceed the plasma threshold considerably [15]. In
any case, when the proteins are absorbed, lysosom-
al combination and intracellular digestion occur and
the resultant peptides or amino acids either dis-
appear into the metabolic machinery of the cell or
are returned to the contralumenal circulation. The
number and nature of individual proteins that might
be absorbed and returned intact to the peritubular
circulation is in dispute. Similarly, controversy sur-
rounds the magnitude of cellular uptake of protein
from the peritubular circulation, although the exis-
tence of such a process seems well established, at
least for certain protein hormones such as insulin
[15].
Physicochemical factors. The transglomerular
passage of plasma proteins has been examined in
humans and experimental animals during the ad-
ministration of several types of macromolecules.
Dextran, a polymer of glucose with minimal tubular
reabsorption, has been used most commonly. The
use of dextrans of known molecular size to study
the renal handling of macromolecules was pio-
neered by Wallenius [16] and recently was amplified
by Chang et al [17-19]. Wallenius demonstrated that
the glomerular filtration of dextrans decreased
sharply as their effective molecular radius increased
above 20 A and that transglomerular passage was
minimal at molecular sizes greater than 34 A. Small-
sized plasma proteins such as ribonuclease and
lysozyme also are known to traverse the glomerular
capillary walls readily. In fact, some proteins have
glomerular sieving coefficients as high as 0.9 [15].
Observations such as these have suggested that gb-
merular filtration involves molecular sieving
through the functional equivalent of aqueous pores
[20]. That is, molecular size and shape are the major
determinants of the transglomerular passage of
macromolecules. This physical phenomenon is
summarized by the term steric hindrance, the value
of which primarily depends on the ratio of the ef-
fective radius of the solute molecule to the radius of
the pore. In addition to size and shape, however,
electrical forces also are involved in macromolecu-
lar passage through the glomerular capillary wall.
The electrical forces are summarized by the term
electrostatic hindrance, the phenomenon whereby
the mobility of macromolecules through the gb-
merular wall is hindered or facilitated by electrical
interactions between cationic or anionic groups on
the solute and areas of charge density on the chan-
nel wall. Chang et al have demonstrated that the
permeability of the normal rat glomerulus to poly-
anionic dextran sulfate is considerably lower than is
the permeability to similarly sized molecules of neu-
tral dextran [18]. Moreover, neutral dextrans hav-
ing effective radii of 36 A pass through the glomeru-
lar capillary wall more easily than does albumin,
which has the same effective radius (36 A), but
which exists in plasma as a polyanion at physiologic
pH. The addition of negatively charged sulfate radi-
cals to the dextran molecule results in its passage
across the glomerular barrier being impaired to the
same degree as albumin. Conversely, the trans-
glomerular passage of positively charged dextran
molecules of the same size was facilitated [9, 21-
24]. Thus, among the physicochemical factors that
influence the ability of a macromolecule to cross the
gbomerular ultrafiltration barrier, both electrostatic
and steric hindrance must be considered. In relative
terms, electrostatic factors probably play a lesser
role in determining the transglomerular passage of
the smallest macromolecules. Electrical charge
probably assumes greater importance as the ef-
fective radius of the macromolecule approaches the
diameter of the theoretical "pore." The magnitude
398 Nephrology Forum
of relative interplay between electrical charge ver-
sus molecular size and shape as determinants of
transglomerular passage has not yet been estab-
lished for any significant number of plasma pro-
teins.
Hemodynamic factors. In addition to phys-
icochemical considerations, renal hemodynamic al-
terations provide other major influences on the
transglomerular passage of macromolecules [20].
The mechanisms whereby hemodynamic changes
affect urine protein excretion, however, are not well
understood. One must remember that convective
and diffusive forces are important theoretical de-
terminants of macromolecular transport across the
capillary wall, and that these forces are also influ-
enced by glomerular hemodynamics. Administra-
tion of vasoactive compounds such as angiotensin
[25, 26] and norepinephrine [27], assumption of the
upright posture [28, 29], and exercise [4] all can lead
to increased urine protein excretion. Proteinuria in
these settings has been attributed to a function of
the reduced renal blood flow and altered glomerular
hemodynamics. Local increases in protein concen-
tration along the glomerular capillaries (when gb-
merular plasma flow is reduced and filtration rate is
relatively well maintained), increases in the per-
meability of the limiting gbomerular membrane or its
surface area available for transport, and increases
in transglomerular pressure might be some of the
mechanisms responsible.
Mechanisms Qfabnormalproteinuria
The major mechanisms whereby increased
amounts of protein appear in the urine are: (1) ele-
vated plasma concentrations of normal or abnor-
mal proteins ("overflow" proteinuria such as ly-
sozymuria in leukemia or Bence-Jones proteinuria
[30]; (2) direct addition of proteins to tubular fluid
by the renal tubular epithelium (Tamm-Horsfall
proteinuria) [31, 32]; (3) altered renal tubular reab-
sorption of normal amounts of filtered proteins
[33—36]; and (4) an altered capillary wall with a re-
sultant increase in permeability secondary to a loss
of glomerular polyanions or other causes of de-
creased permselectivity [9]. Whatever the cause of
abnormal proteinuria, its magnitude can be in-
creased by the same renal hemodynamic changes
that are capable of increasing protein excretion by
the healthy kidney. Little is known about the rela-
tive contribution of these mechanisms to the gene-
sis of "isolated" proteinuria in asymptomatic pa-
tients. In view of the undoubted heterogeneity of
the patient population with this syndrome, we logi-
cally can suspect that any of the possible mecha-
nisms might be operative in a given patient at a giv-
en time.
Against this background, let us turn to a detailed
consideration of the clinical significance and, when
possible, the mechanisms of isolated proteinuria in
asymptomatic and apparently healthy patients.
Clinical significance of proteinuria
in apparently healthy patients
Uncertainty still surrounds the clinical signifi-
cance of "isolated" proteinuria. Several factors are
responsible for this state of affairs. First, it has long
been known that qualitative proteinuria occurs both
in the presence and absence of underlying histologic
alterations of renal structure [37—47]. Second, al-
though progressive renal disease appears subse-
quently in some patients [37, 48-49], one study has
shown that the incidence of proteinuria in young
adults is greater than the incidence of subsequent
death from renal failure [50]. This finding strongly
suggests that kidney disease might not exist in many
such patients or that if it does, it does not cause
death from renal failure. Third, we must recognize
that conclusions derived from a study of one popu-
lation are not necessarily applicable to another
group. Finally, a profuse array of descriptive terms
has been applied frequently to proteinuria observed
in apparently healthy patients; juvenile, physiolog-
ic, orthostatic, constant, persistent, cyclic, inter-
mittent, isolated, benign, minimal, and transient
comprise only a partial list of the descriptive terms.
In many instances, these terms have not been de-
fined clearly; in others, the use of differing criteria
has complicated the comparison of results between
studies.
For these reasons, the exact definition of the clin-
ical characteristics of the proteinuric population un-
der consideration is of great importance. The re-
mainder of the present discussion will focus exclu-
sively on the clinical significance of proteinuria in a
single, large, and arbitrarily defined adult popu-
lation of patients in whom proteinuria is always first
observed as an isolated" clinical finding. It will
apply only to patients who are asymptomatic and
seemingly healthy at the time of initial examination,
and who exhibit no evidence of systemic disease,
impaired renal function, or any abnormality of the
urine sediment. Excretory urography and nuclear
or ultrasonic imaging are always within normal lim-
its, and the patients have no history of kidney or
genitourinary tract disease. In such patients, pro-
teinuria is often first detected during a routine phys-
ical examination, perhaps in preparation for en-
trance into military service, participation in an ath-
letic program, or application for life insurance or
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employment. Daily total protein excretion is usual-
ly, but not necessarily, less than 1.0 g. Most pa-
tients thus far described have been relatively young
adults at the time of initial clinical presentation, but
this fact might be related to the paucity of com-
parable survey observations in older populations.
Neither the incidence nor prevalence of proteinuria
as an isolated finding among various age or popu-
lation groups is certain. Estimates of the incidence
of qualitative proteinuria during casual or routine
urinalysis in military inductees and other adult pop-
ulations have varied widely, ranging from values of
0.6% to 8.8% [51—54].
Classification of isolated proteinuria. What meth-
ods should one use in assessing the clinical signifi-
cance of isolated proteinuria in an individual pa-
tient? In general, proteinuria has been classified ac-
cording to two clinical approaches, one without
regard to body posture, and the other taking body
posture into account. Using the first approach, the
pattern of protein excretion on repeated qualitative
testing is designated "transient" or "intermittent"
if proteinuria comes and goes, and "persistent" if
proteinuria is found on analysis of all specimens. In
the second approach, "serial urine collection tests"
identify proteinuria as "constant" if it is present
both during recumbency and during quiet upright
ambulation, "fixed and orthostatic" if it is present
consistently only in the upright posture, and "tran-
sient" or "intermittent'' and "orthostatic'' when it
is present inconsistently only in the upright posture
[55, 56]. Multiple urinalyses must be performed at
the time of initial examination to identify the pattern
correctly. The significance of many of these arbi-
trarily classified types is not certain: the various
types probably should be viewed not as specific
clinical entities, but as consequences of diverse
causes and mechanisms. Further, even the relation-
ship between persistent and constant proteinuria, as
just defined, has not been delineated clearly. Al-
though it seems likely that patients with these pat-
terns are drawn from similar populations, studies
using both approaches, that is, with and without re-
gard to posture, have not been performed in the
same individuals. I would now like to discuss these
two different approaches to the investigation and
classification of isolated proteinuria.
Classification according to repetitive urinalysis
without control of body posture. As noted above, at
least two distinct qualitative patterns of isolated
proteinuria emerge when routine urinalyses are car-
ried out repetitively over a short period: the per-
sistent presence of qualitative proteinuria, or the in-
termittent or transient presence of qualitative pro-
teinuria. Several years ago, Levitt performed a
retrospective study to establish the clinical signifi-
cance of these types of proteinuria [50]. The study
group comprised graduates of the University of
Minnesota who were given repetitive urinalyses on
entrance to the university in 1925; each had qualita-
tive proteinuria. By 1966, 41 years later, the mortal-
ity rate of this group was compared with that of pre-
sumably healthy 18-year-olds who had undergone
examinations for life insurance in 1925, and whose
urinalyses revealed no proteinuria qualitatively.
The mortality rate was significantly higher in the pa-
tients who had had qualitative proteinuria in more
than 80% of their initial urinalyses, that is, those
with persistent proteinuria. In contrast, no dif-
ference in mortality rate was noted in the patients
who had had proteinuria in less than 50% of their
initial specimens, that is, those with intermittent or
transient proteinuria. These findings imply that the
long-term outlook is worse when repetitive exami-
nation reveals persistent proteinuria.
In France, Antoine et al studied 16 patients in
whom persistent proteinuria was an isolated finding
[37]. Percutaneous renal biopsy revealed a hetero-
geneous spectrum of morphologic alterations in 12
of the 16 patients. Nevertheless, only 2 of these pa-
tients developed renal insufficiency after follow-up
periods ranging from 8 to 28 years. The authors con-
cluded that even in patients with documented renal
pathology, the progression to renal failure is re-
markably indolent. Included in Antoine's study
were 10 other patients with the same clinical and
histologic findings as the 16 patients described
above, but these 10 also had microscopic hema-
tuna. This single additional indicator of disease ac-
tivity was attended by more rapid progression of
renal functional impairment.
Classification according to repetitive urinalysis
with control of body posture. For many years we
have used a simple serial urine collection test to re-
late the qualitative appearance of proteinunia to
changes of body posture [55, 56]. When the test is
conducted during moderate antidiuresis, results are
reproducible in the same patient over short periods
of time. On the morning after overnight fluid depri-
vation, two or more urine samples are collected
consecutively during each of two sequentially as-
sumed body postures: recumbency and quiet up-
right ambulation. Artificial upright lordosis is not in-
duced. A qualitative test for protein (10% sulfosali-
cylic acid) and a measurement of urine osmolality
are performed on each urine sample.
As noted previously, one of three qualitative pat-
terns emerges in an individual patient. Constant
proteinuria occurs in approximately 5% to 10% of
young men with proteinuria on routine urinalysis
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where posture is not controlled [561. Fixed and re-
producible orthostatic proteinuria occurs in approx-
imately 15% to 20% of young men whose protein-
uria is detected initially on routine urinalysis [56].
As I mentioned earlier, this type of proteinuria was
initially exhibited by the patient under discussion
today. Transient orthostatic proteinuria is claimed
by King to be the most common of the three postur-
ally defined patterns, perhaps occurring in 70% to
75% of young men with isolated proteinuria on rou-
tine urinalysis [56]. Unfortunately, transient ortho-
static proteinuria has been studied far less
thoroughly than have either fixed and reproducible
orthostatic proteinuria or constant proteinuria. Ap-
proximate incidence figures for these types of pro-
teinuria are available only for young men; similar
figures are not available for women or other age
groups.Quantitative measurements of total protein ex-
cretion have been carried out in patients who have
clear evidence of constant proteinuria and fixed and
reproducible orthostatic proteinuria. Values for to-
tal protein excretion are often higher even during
recumbency in patients with fixed and reproducible
orthostatic proteinuria than in healthy patients
whose qualitative tests are negative for protein in
both the recumbent and upright postures [28, 29].
But the amount of protein excreted is not suffi-
ciently high to permit detection with the usual quali-
tative tests. The significance of this finding has not
been established, nor is its occurrence known to be
universal in patients with a qualitative pattern of or-
thostatic proteinuria other than that termed fixed
and reproducible. Indeed, quantitative protein ex-
cretion during recumbency might well be within
normal limits in patients with transient orthostatic
proteinuria [57].
(A) "Constant" proteinuria. For many years
"constant" proteinuria, even as an isolated finding,
has been regarded as prima facie evidence of kid-
ney disease. Definite morphologic evidence of di-
verse forms of kidney disease is found by renal
biopsy in most instances. Most of these patients
probably have proteinuria that is persistent on re-
petitive routine urinalysis without postural control.
In view of the marked diversity of the underlying
renal pathology, it is illogical to expect that all such
patients will follow an identical clinical course.
Nevertheless, the clinical course of constant pro-
teinuria is remarkably indolent in the absence of
other indicators of active disease such as micro-
scopic hematuria. Although few long-term follow-
up studies of patients with constant proteinuria
have been performed, the results of one study
demonstrated that approximately 80% of such pa-
tients still exhibited constant proteinuria after an
average 6-year period. Of these, the majority had
developed abnormal urine sediment, and almost
50% had developed mild hypertension, but very few
had developed renal insufficiency [48, 49].
(B) Orthostatic proteinuria. The exact clinical
significance of islolated orthostatic proteinuria re-
mains controversial. In contrast to constant pro-
teinuria, orthostatic proteinuria has been regarded
as a benign and transient condition not associated
with underlying kidney disease [58—60]. This con-
cept of the disorder might be true in many patients,
particularly in children. Other observations, how-
ever, have suggested that orthostatic proteinuria
might be a reflection of incipient kidney disease, at
least in some patients [49, 61]. This controversy
cannot be resolved until complex clinical and physi-
ologic issues are clarified. To shed some light on the
significance of ortho static proteinuria, I would now
like to examine the renal biopsy findings in these
patients, the possible mechanisms involved in the
proteinuria, and our long-term prospective studies.
Light-microscopic studies of kidney biopsy speci-
mens from young adult males with fixed and repro-
ducible orthostatic proteinuria revealed that 8% had
unequivocal evidence of renal disease, 45% had
subtle but definite alterations of glomerular struc-
ture (segmental or generalized capillary wall thick-
ening without alteration of the basement mem-
brane, or focal and segmental hypercellularity), and
47% exhibited a histologic pattern that appeared
normal [45]. A limited number of electron-micro-
scopic observations have confirmed a subtle form of
segmental and focal glomerular alterations [46, 62],
and immunohistologic studies have shown that both
immunoglobulin and complement are localized
within such foci [63]. Recent histologic observa-
tions in patients with intermittent orthostatic pro-
teinuria demonstrate minimal changes without im-
munoprotein on immunofluorescent microscopy,
but only a small number of such patients have been
studied [47].
The mechanism by which assumption of the quiet
upright posture effects increased protein excretion
is still uncertain. Regardless of the exact nature of
the glomerular changes just described, their exis-
tence provides one possible explanation for the pro-
teinuria, that is, an underlying capillary wall defect,
which facilitates an increased transglomerular pas-
sage of plasma proteins. By itself, however, the ex-
istence of an altered capillary wall does not explain
abnormal protein excretion occurring only during
quiet upright ambulation [57]. Earlier researchers
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postulated that any one of the several renal hemo-
dynamic adjustments to standing might serve as the
primary cause of orthostatic proteinuria; renal
venous congestion or ischemia and a reduction of
filtration rate all have been implicated [58, 64]. This
hypothesis became suspect when it was shown that
the upright renal hemodynamic response was no
different in patients with fixed orthostatic protein-
uria than it was in normal subjects [20, 65]. A quan-
titatively similar reduction of renal plasma flow and
filtration rate, and an elevation of filtration fraction
were observed in both groups. Of these three pos-
sible hemodynamic determinants of transglomerular
protein transfer, the results of clearance studies [28]
indicated to us that the normal reduction of plasma
flow was of greatest importance. For example, ex-
perimentally induced renal vasodilation that obliter-
ated the usual reduction of renal plasma flow was
accompanied by a strikingly smaller rise of protein
excretion than usual. We suggested that some func-
tion of the reduction of renal blood or plasma flow
might secondarily permit an increased protein
transfer across an altered capillary wall. According
to this view, the combination of an altered capillary
wall and the normal reduction of renal blood flow in
the upright posture might be sufficient to effect an
increased transglomerular passage of protein that
readily exceeds the normal tubular reabsorptive ca-
pacity. One can speculate that the secondary hemo-
dynamic contribution to fixed orthostatic protein-
uria might be similar to that occurring during the
administration of angiotensin in experimental ani-
mals [25, 26]. This hypothesis is tentative and other
possibilities exist. For example, an upright altera-
tion of renal tubular reabsorption of protein has not
yet been excluded. Alternatively, increased capil-
lary permeability to plasma proteins during standing
might be mediated via a direct effect of certain hu-
moral agents on an altered capillary wall, agents
whose release is also increased by postural
changes. Such a role has been suggested for renin,
angiotensin, and circulating vasoactive amines be-
cause of their capacity to produce proteinuria in an-
imals [25-27, 66, 67].
Whatever the role of the alterations of glomerular
structure in the pathogenesis of fixed and reproduc-
ible orthostatic proteinuria, only long-term prospec-
tive studies can determine their clinical signifi-
cance. Our own 10-year follow-up study of young
men with an initial diagnosis of fixed orthostatic
proteinuria demonstrated that 49% still exhibited
qualitative proteinuria [61]. No evidence of renal
functional impairment or progressive renal disease
had appeared in any of the patients, including the
patient presented today. Furthermore, no relation-
ship existed between the initial renal histology and
the subsequent pattern of renal function of protein-
uria. In short, the 10-year prognosis of young men
with fixed and reproducible orthostatic proteinuria
is excellent. A similarly benign intermediate-term
course of 5 to 10 years has been described by other
observers [67-69].
The significance of the subtle glomerular altera-
tions that we found in 45% of our patients is uncer-
tain, but the decreasing frequency of proteinuria
and the preservation of normal renal function in this
group suggests that the glomerular findings are not a
manifestation of progressive renal disease. Until
more time elapses, however, we cannot exclude the
possibility that renal function will deteriorate in the
patients who still had proteinuria when studied 10
years after the initial evaluation. As I mentioned
previously, these results are not surprising in view
of the heterogeneity of the histologic alterations.
Taken together, these findings suggest that fixed
and reproducible orthostatic proteinuria does not
necessarily represent a transient condition of ado-
lescence—in some patients it might reflect the
earliest expression of future renal disease. Contin-
ued observation is necessary to establish the validi-
ty of this hypothesis. In fact, our patient today is
one whose return visit in 1979 was occasioned by
his willingness to participate in the 20-year follow-
up study of our original group of patients. Obvious-
ly, he has continued to do well. Because his protein-
uria is now transient and his renal function has re-
mained normal, I strongly suspect that his long-
term prognosis is excellent. Our 20-year follow-up
study, in cooperation with Drs. P. Springberg and
L. Garrett at Wilford Hall USAF Medical Center
and Dr. A. L. Thompson at the University of Ne-
vada Medical Center, is just now underway so our
observations are only preliminary. We have, how-
ever, reexamined 18 of the original 64 patients, and
to date none has developed renal insufficiency. We
hope the number of participants in the 20-year fol-
low-up study will be large enough to permit mean-
ingful comparisons with the earlier follow-up exam-
inations [61].
Virtually no long-term data are available in pa-
tients with transient orthostatic proteinuria, but
most clinicians believe that the prognosis of pa-
tients with this finding is excellent [50]. In many
such patients, transient episodes of orthostatic pro-
teinuria might reflect nothing more than fever, exer-
cise, or exposure to environmental factors such as
heat or cold. Indeed, as in angiotensin-induced pro-
teinuria in the rat, this form of upright proteinuria
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might reflect nothing more than a transient and ex-
aggerated renal hemodynamic response to these or
other stimuli.
Summary of renal structural alterations in patients with
'isolated" proteinuria
Renal biopsy specimens have been examined
from patients in the five descriptive categories of
isolated proteinuria I have used: persistent or inter-
mittent proteinuria (defined on sequential routine
urinalysis without control of body posture) [37, 40,
41]; constant proteinuria during both recumbent
and upright postures [43]; and transient [47] or fixed
and reproducible orthostatic proteinuria as defined
during appropriate postural maneuvers [43, 45]. In
four of the five categories examined so far, a vary-
ing but important incidence of "definite" histologic
alterations has been reported (about 10% to 70%),
all of which have been sufficiently distinct to war-
rant a firm histologic diagnosis of renal disease
("definite" histologic alterations have not yet been
reported in patients with transient orthostatic pro-
teinuria). The lesions themselves have been ex-
tremely heterogeneous, and a consistent relation-
ship has not been observed. The incidence of defi-
nite renal pathology has been found to be similarly
high (about 40% to 70%) in patients with persistent,
intermittent, or constant proteinuria [37, 40, 43, 70],
whereas a much lower figure (about 10%) has been
found in patients with fixed orthostatic proteinuria
[45]. In other patients from all five of the groups, the
incidence of disparate but minimal alterations has
been similarly variable (about 10% to 70%). In still
others, perhaps most frequently in patients with
transient or fixed orthostatic proteinuria, the renal
architecture has appeared entirely normal on light
microscopy [45, 47], although subtle architectural
"defects" of the glomerulus have been described
on electron microscopy in a few patients [46, 61]. It
seems safe to conclude that, with the possible ex-
ception of transient orthostatic proteinuria, (1) each
of these five types of proteinuria is associated with a
broad spectrum of histologic findings ranging from
normal renal architecture to definite evidence of
disease; (2) a similarly heterogeneous display of un-
derlying renal pathology or architectural alteration
occurs in each type but the frequency of definite
disease is lowest by far in patients with transient
or fixed orthostatic proteinuria; and (3) no ab-
solute relationship exists between the type of pro-
teinuria and the presence or absence of renal
pathology. Renal biopsy remains the only means of
distinguishing between the patient with structural
renal disease and the one without.
Unfortunately, the description of definite patho-
logic alterations per se does not provide any neces-
sary insight into their actual clinical significance as
a cause of subsequent morbidity or mortality. One
still must determine whether a particular lesion is
static, resolving, or progressing. Prospective stud-
ies are clearly required. We also must continue our
search for functional indexes of disease activity as
an aid to determining the activity of the pathologic
lesions.
In our approach to the management of patients
with isolated proteinuria, we emphasize yearly fol-
low-up evaluation. The initial evaluation includes a
thorough physical examination, a determination of
the persistence of a given qualitative pattern, urinal-
ysis, and measurements of quantitative protein ex-
cretion and endogenous creatinine clearance. Ultra-
sonography is sometimes performed as well. Renal
biopsy usually is not undertaken unless there is a
distinct change in the clinical course, such as an
abrupt and definite increase in daily protein excre-
tion, the appearance of distinct and persistent ab-
normalities of the urine sediment, or impairment of
renal function.
It is interesting to speculate that a persisting pat-
tern of qualitative proteinuria over several years—
whether it be persistent, intermittent, fixed, or tran-
sient orthostatic or constant in type—might be at-
tended by an important incidence of underlying re-
nal pathology [41-46, 50, 51]. In fact, it would not
be surprising to observe in the same patient at dif-
ferent times over a relatively long period different
types of proteinuria, because its detection depends
on the simultaneous interaction of many variables
(for example, posture, urine concentration, and the
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Fig. 1. Sequential relationship between quantitative protein ex-
cretion and qualitative tests for urine protein in a hypothetical
patient with progressive renal disease (Reprinted with per-
mission from S. Karger [711).
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natural history of an underlying disease process)
[71]. Figure 1 depicts a hypothetical patient whose
disease progression is accompanied by a variable
but steady increase of total protein excretion during
both recumbency and upright ambulation. Depend-
ing on the relationship between the lower limits of
qualitative urine protein detection and the changing
influences on urine protein excretion, an ever-
changing pattern of qualitative proteinuria will
emerge. At various times, a patient might exhibit
intermittent or transient orthostatic proteinuria, or
perhaps it might seem to become fixed for a variable
period [71]. Eventually, quantitative protein excre-
tion might rise sufficiently to permit its qualitative
detection in both recumbent and upright specimens,
that is, the proteinuria becomes constant. Some pa-
tients move through this sequence so explosively
that constant proteinuria seems to exist from the
very onset of disease. In others, the disease prog-
resses so slowly that a variable but generally ortho-
static pattern is observed for years. Eventually, if
the underlying disease progresses sufficiently, pro-
tein excretion can rise during recumbency and yield
the pattern of constant proteinuria; alternatively,
the disease process can heal, and proteinuria dis-
appears completely. Considerations such as these
should underscore the difficulties that beset any at-
tempt to relate a given clinical observation to any
particular pattern of qualitative proteinuria. Never-
theless, although the long-term prognosis still must
be regarded with reservation, if persistent protein-
uria is the sole alteration, the 10-year outlook is ex-
cellent in most patients, as in the patient presented
today.
Questions and answers
DR. JEROME P. KASSIRER: Our approach to the
diagnosis of orthostatic proteinuria has been to
measure protein excretion using a quantitative sul-
fosalicylic acid method during 8 hours of recum-
bency and again during 16 hours of routine activities
in the upright posture. Using this method we have
diagnosed orthostatic proteinuria when protein ex-
cretion is abnormal only in the upright posture. Do
you think there is any advantage to this quantitative
approach over the qualitative method you used?
DR. RoBINsoN: I don't know. Unfortunately, too
few descriptions have been published about the
relationship between recumbent and upright quan-
titative values for total urinary protein excretion
and the qualitative patterns I have described. At
least in patients with fixed orthostatic proteinuria,
however, quantitative excretion seems usually to be
increased during recumbency, but the protein ex-
cretion does not rise sufficiently to permit qualita-
tive detection. I cannot say whether that is the case
in transient or intermittent proteinuria. Resolution
of the question also depends on the sensitivity of
our methods for quantifying small amounts of pro-
teinuria and the adequacy of our definition of the
"normal" range of protein excretion in the recum-
bent posture.
DR. KASSIRER: We occasionally observe patients
who, in the course of recovering from the nephrotic
syndrome or poststreptococcal nephritis, show an
orthostatic pattern of protein excretion. These pa-
tients seem to have a benign long-term prognosis. Is
there any solid evidence to support this contention?
DR. ROBINSON: I don't know the answer to that
question either. I know of no solid data that relate
prognosis in those disorders to the presence or ab-
sence of orthostatic proteinuria at some time during
the clinical course.
DR. CECIL H. COGGINS (Acting Chief, Renal
Unit, Massachusetts General Hospital, Boston): In
reviewing the literature on patients with mild to
moderate proteinuria, I cannot find very much good
data correlating the clinical information with so-
phisticated histologic analysis. In a few surveys, pa-
tients were biopsied but not followed, and even in
these studies the biopsies usually were not exam-
ined by electron microscopy or immunofluo-
rescence. I believe that you and your colleagues
have carried out the few studies that do correlate
reliable clinical information with solid pathologic
analysis.
DR. ROBINSON: Thank you, Dr. Coggins. I agree
that there are too few prospective followup studies.
Parenthetically, insofar as our own studies are con-
cerned, most of the paraffin blocks containing the
original biopsy specimens are still available. In the
near future, I hope that we can reexamine new sec-
tions from these blocks for comparison with those
cut originally. It will be interesting to note the simi-
larity or lack thereof between our original morpho-
logic interpretations and those made independently
20 years later.
DR. JORDAN J. COHEN: Let us assume that your
reexamination of the original biopsy material con-
firms your initial impression that asymptomatic pa-
tients with mild proteinuria often have detectable
histologic changes. To interpret such a finding, one
would have to know the spectrum of histologic find-
ings in truly normal persons without proteinuria.
Are sufficient histologic data available to define
what the normal spectrum is?
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DR. ROBINSON: I think we have a far better un-
derstanding today than we did in 1958 to 1960. For
instance, kidney biopsies performed one hour after
renal transplantation in well-matched siblings offer
one basis for comparison. Nevertheless, determin-
ing a precise definition of normal can be a very diffi-
cult task.
DR. KENNETH SHAPIRO (Renal Fellow,
NEMCH): You alluded to the possible role of angio-
tensin in the pathogenesis of postural proteinuria.
Are you aware of any studies using angiotensin
blockers or indomethacin to treat this condition?
DR. RoBINsON: No, there are none to my knowl-
edge.
DR. JOHN T. HARRINGTON: Dr. Robinson, your
studies on postural proteinuria have given us a great
deal of insight into the significance of proteinuria of
less than 1 g/day. Dr. Coggins recently published
the first full results of the Adult Idiopathic Nephro-
tic Syndrome Collaborative Study analyzing patients
with proteinuria greater than 3.5 g/day [72]. I am
interested in your thoughts regarding the group in
the middle, that is, those who excrete 1 to 3 g of
protein per day.
DR. RoBINsON: In general, it is my bias that the
greater the degree of proteinuria, the higher the
likelihood of underlying kidney disease. Depending
on the results of the urine sediment examination, I
might wish to further test a patient who excretes 1
to 3 g of urinary protein per day. Some clinicians
would say that renal biopsy should be performed if
the excretion rate is greater than 2.0 g/day. If pro-
teinuria of such magnitude is an isolated finding, I
believe that one can postpone biopsy until the first
appearance of a change in clinical status. Overall, I
suspect that the subsequent appearance of such
changes will be much more frequent and earlier
than it is in patients with lesser degrees of protein-
uria. A good study of these patients, which corre-
lates long-term clinical information with modern
renal pathology, is needed.
Reprint requests to Dr. R. R. Robinson, Box 30/4, Duke Uni-
versity Medicol Center, Durhom, North Carolina 27710, U.S.A.
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